Literature DB >> 3707333

Treatment of pyogenic hepatic abscesses. Surgical vs percutaneous drainage.

C K Bertel, J A van Heerden, P F Sheedy.   

Abstract

A retrospective review of 39 patients with pyogenic hepatic abscess treated from 1977 through 1984 included 23 patients who were surgically treated and 16 who underwent percutaneous drainage. The average age in each group was similar (about 55 years). The most common cause of abscesses in each group was biliary tract disease. Abscesses caused by portal seeding and local extension were more common in the surgical group, 14 of whom required additional surgical procedures at the time of surgical drainage. Of the 16 patients in the percutaneously drained group, seven were seen during the immediate postoperative period. Most of the abscesses occurred in the right lobe of the liver, but single abscesses in the left lobe (30%) and multiple abscesses (57%) were more common in the surgical group. Klebsiella enterobacter and group D streptococcus were most common in the surgically and percutaneously drained groups, respectively. All patients received antibiotics, with a mean length of treatment of 14 days. Mean time to defervescence was about four days in both groups, with a longer hospital stay for the percutaneously drained group (26 vs 46 days). Morbidity was high in both groups (surgical, 48%; percutaneous, 69%). Three of the percutaneously treated patients required surgical drainage because of highly viscous abscess contents. Mortality was 17% in the surgical group and 13% in the percutaneously drained group. Percutaneous drainage with computed tomography probably should be the initial drainage procedure in patients with pyogenic hepatic abscesses in whom no concomitant surgical procedure is planned. Regardless of treatment, the morbidity and mortality remain high.

Entities:  

Mesh:

Year:  1986        PMID: 3707333     DOI: 10.1001/archsurg.1986.01400050072009

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  27 in total

1.  Percutaneous treatment of pyogenic liver abscess: a critical analysis of results.

Authors:  R F Dondelinger; J C Kurdziel; C Gathy
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Jun-Jul       Impact factor: 2.740

Review 2.  Hepatic applications of endoscopic ultrasound: Current status and future directions.

Authors:  Indu Srinivasan; Shou-Jiang Tang; Andreas S Vilmann; John Menachery; Peter Vilmann
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

3.  An appraisal of surgical and percutaneous drainage for pyogenic liver abscesses larger than 5 cm.

Authors:  Yu-Meng Tan; Alexander Yaw-Fui Chung; Pierce Kah-Hoe Chow; Peng-Chung Cheow; Wai-Keong Wong; London Lucien Ooi; Khee-Chee Soo
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

4.  Pyogenic liver abscess: multivariate analysis of risk factors.

Authors:  K T Lee; P C Sheen; J S Chen; C G Ker
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

Review 5.  Percutaneous abscess and fluid drainage: a critical review.

Authors:  R E Lambiase
Journal:  Cardiovasc Intervent Radiol       Date:  1991 May-Jun       Impact factor: 2.740

6.  Percutaneous drainage of pyogenic liver abscesses.

Authors:  K P Wong
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

7.  Diagnosis of anaplastic pancreatic cancer with multiple liver metastases.

Authors:  S Yamagishi; M Ohta
Journal:  Postgrad Med J       Date:  1998-07       Impact factor: 2.401

Review 8.  Imaging intraabdominal abscesses and nonoperative drainage procedures.

Authors:  J R Haaga
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

9.  Percutaneous aspiration versus catheter drainage of liver abscess: A retrospective review.

Authors:  Gurjeet Dulku; Geeta Mohan; Shaun Samuelson; John Ferguson; Jonathan Tibballs
Journal:  Australas Med J       Date:  2015-01-31

Review 10.  Laparoscopic drainage of cryptogenic liver abscess.

Authors:  Liza Tan; Hui Jun Zhou; Mikael Hartman; Iyer Shridhar Ganpathi; Krishnakumar Madhavan; Stephen Chang
Journal:  Surg Endosc       Date:  2013-03-15       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.